Track the 폴라리스AI파마 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Technology sector, 폴라리스AI파마 has recorded 14 reports. Market capitalisation: €7.7m. The latest transaction was disclosed on 10 July 2026 (Purchase). Among the most active insiders: 폴라리스AI파마. Every trade is openly available.
13
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 27,008 of 28,958 companies
18.1
score / 100
Value
12
Quality
25
FCF yld-12%
Earn yld-29%
EV/EBITDA·
ROE-63%
Gross mgn31%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Polaris AI Pharma is a technology company listed on the XKRX market. It specializes in developing artificial intelligence solutions for the pharmaceutical industry.